Rethinking the Optimal Path for Rectal Cancer: Upfront Surgery and Neoadjuvant Therapy

In recent years, the debate between upfront surgery and neoadjuvant therapy has become a cornerstone in the management of rectal cancer. Choosing the optimal path requires a deep understanding of varying international guidelines and the precision offered by modern surgical techniques. Thanks to the integration of laparoscopic and robotic-assisted systems, surgeons can now achieve higher levels of precision in Local Axial Resection (LAR), adhering to rigorous clinical standards to improve patient quality of life.

Clinical Background

1. Welcome and Introduction - by Dr. Soichiro Ishihara (Japan)

2. Advanced Lower Rectal Cancer: Clinical Guidelines and Surgical Excellence in Robotic LAR - Dr. Yoshiro Itatani (Japan)

3. The UK/European Perspective: Guidelines, Strategies, and the Upfront Surgery Debate - Dr. Jim S. Khan (UK)

4. Precision in Practice: Laparoscopic LAR Following Japanese Guidelines - Dr. Soichiro Ishihara (Japan)

5. Panel Discussion & Closing Remarks - Moderated by Dr. Soichiro Ishihara (Japan)